Viewing Study NCT00027560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-03-08 @ 1:48 AM
Study NCT ID: NCT00027560
Status: COMPLETED
Last Update Posted: 2013-01-07
First Post: 2001-12-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent childhood acute lymphoblastic leukemia View
None recurrent adult Hodgkin lymphoma View
None refractory multiple myeloma View
None stage II multiple myeloma View
None stage III multiple myeloma View
None recurrent childhood lymphoblastic lymphoma View
None recurrent childhood acute myeloid leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None relapsing chronic myelogenous leukemia View
None refractory chronic lymphocytic leukemia View
None recurrent/refractory childhood Hodgkin lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None previously treated myelodysplastic syndromes View
None recurrent childhood small noncleaved cell lymphoma View
None recurrent childhood large cell lymphoma View
None recurrent mantle cell lymphoma View
None Waldenström macroglobulinemia View
None childhood chronic myelogenous leukemia View
None atypical chronic myeloid leukemia, BCR-ABL1 negative View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None childhood myelodysplastic syndromes View